BCR Wealth Strategies’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-235
Closed -$212K 30
2024
Q2
$212K Buy
+235
New +$188K 0.14% 29
2022
Q4
Sell
-224
Closed -$72K 62
2022
Q3
$72K Buy
224
+24
+12% +$7.6K 0.07% 32
2022
Q2
$65K Hold
200
0.07% 30
2022
Q1
$57K Hold
200
0.05% 37
2021
Q4
$55K Buy
+200
New +$50.7K 0.05% 41

Other funds holding LLY

BCR Wealth Strategies's LLY Position: Q3 2024 in Review

BCR Wealth Strategies sold out of Eli Lilly (LLY) in Q3 2024, closing a stake of 235 shares — an estimated $212K sold.

BCR Wealth Strategies first reported a position in LLY in Q4 2021 and held it in 5 quarters. The position peaked at $212K in Q2 2024. 3,657 funds tracked by Wall St. Rank hold LLY as of Q3 2024.

  • BCR Wealth Strategies reported no remaining Eli Lilly position as of Q3 2024 after selling out during the quarter.
  • BCR Wealth Strategies sold 235 Eli Lilly shares in Q3 2024, an estimated $212K.
  • BCR Wealth Strategies first reported a position in Eli Lilly in Q4 2021 and held it in 5 quarters.
  • BCR Wealth Strategies's Eli Lilly position peaked at $212K in Q2 2024.
  • 3,657 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2024.

Based on BCR Wealth Strategies's 13F filing for Q3 2024, filed 18 Oct 2024.